Paramita Ghosh

Professor

University of California Davis School of Medicine

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Paramita Ghosh is a Professor at the University of California Davis School of Medicine in the United States. Her research areas encompass prostate cancer, cellular signaling mechanisms, and the role of androgen receptor variants in various malignancies. She has contributed significantly to the understanding of tumor biology and chemoresistance through her recent publications.

Articles (17)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (6)

Ruth Vinall

California Northstate University College of Pharmacy

UNITED STATES

View details

J. Kent Leach

UNITED STATES

View details

Damian Genetos

Professor

University of California, Davis

UNITED STATES

View details

xinbin chen

Professor

University of California, Davis

UNITED STATES

View details

Christopher Lucchesi

University of California, Davis

UNITED STATES

View details

jin zhang

University of California, Davis

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Paramita Ghosh

Research Interests

Explore related searches

Contact this professor

About

Articles (17)

The Oncometabolite 2-Hydroxyglutarate Is Upregulated in Post-Prostatectomy PSA Recurrence of Prostate Cancer: A Metabolomic Analysis

Alteration in expression and subcellular localization of the androgen receptor- regulated FAM111A protease is associated with emergence of castration resistant prostate cancer

ANGEL2 Modulates Wild-type TP53 Translation and Doxorubicin Chemosensitivity in Colon Cancer

Alterations in Tumor Aggression Following Androgen Receptor Signaling Restoration in Canine Prostate Cancer Cell Lines

Amiloride sensitizes prostate cancer cells to the reversible tyrosine kinase inhibitor lapatinib by modulating Erbb3 subcellular localization

Clinicopathologic Characterization of Prostatic Cancer in Dogs

Pesticides and Bladder Cancer: Mechanisms Leading to Anti-Cancer Drug Chemoresistance and New Chemosensitization Strategies

Molecular Similarities and Differences between Canine Prostate Cancer and Human Prostate Cancer Variants

Beyond Prostate Cancer: An Androgen Receptor Splice Variant Expression in Multiple Malignancies, Non-Cancer Pathologies, and Development

Androgen receptor transcriptional activity is required for heregulin-1β–mediated nuclear localization of the HER3/ErbB3 receptor tyrosine kinase

Prostate cancer and bone: clinical presentation and molecular mechanisms

Transcriptional-translational conflict: a novel exploitable tumor suppressive mechanism

Untargeted Metabolomics Identify a Panel of Urinary Biomarkers for the Diagnosis of Urothelial Carcinoma of the Bladder, as Compared to Urolithiasis with or without Urinary Tract Infection in Dogs

Comparative Cancer Cell Signaling in Muscle-Invasive Urothelial Carcinoma of the Bladder in Dogs and Humans

Androgen Receptor-Mediated Nuclear Transport of NRDP1 in Prostate Cancer Cells Is Associated with Worse Patient Outcomes

The Androgen Receptor in Prostate Cancer: Effect of Structure, Ligands and Spliced Variants on Therapy

Genistein Combined Polysaccharide (GCP) Can Inhibit Intracrine Androgen Synthesis in Prostate Cancer Cells

Collaborators (6)

Ruth Vinall

J. Kent Leach

Damian Genetos

xinbin chen

Christopher Lucchesi

jin zhang

Make your next move.